Indoco Remedies has successfully completed the transfer of its ophthalmic business division to Sunways (India) Private Limited. This strategic move, finalised on May 18, 2026, involves the sale and transfer of the company’s ophthalmic division across multiple territories, including India and several African nations.
The transfer was executed as a going concern on a slump sale basis, in accordance with the Agreement to Transfer Business (ATB) that was previously approved and disclosed by Indoco Remedies on April 30, 2026. The territories affected by this transaction include Benin, Burkina Faso, Ivory Coast, Mali, Niger, Mauritania, Senegal, Cameroon, Congo, Gabon, Kenya, Botswana, Tanzania, Zambia, Zimbabwe, and Namibia.
The completion of this business transfer marks a significant step for Indoco Remedies, aligning with its strategic objectives and operational goals. The company has ensured that all conditions precedent outlined in the ATB were fulfilled before finalising the transaction.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).